Abstract:Background: Even with long-term complete suppression of the virus through Antiretroviral therapy (ART), people infected with HIV cannot attain optimal immune reconstitution. This phenomenon is called immune reconstitution deficiency, there are no effective therapeutic interventions for immune reconstitution deficiency in modern medicine. Objective: To evaluate the efficacy and safety of ART with Shenling Guben Granules Traditional Chinese medicine in boosting immunological reconstitution compared with ART alone. Methods: This was a randomized, double-blind, placebo-controlled, multi-center clinical trial evaluating the efficacy and safety of ART combined with Chinese medicine. The individuals aged 18–65 years with poor immune reconstitution following ART were included in this trial. The primary outcome was a change in the absolute value of CD4+ T lymphocytes after 72 weeks of combined ART and Chinese medicine administration. Secondary outcomes included changes in CD4+ T lymphocyte functional subpopulations, activated T lymphocyte subpopulations, CD4+ T lymphocyte proliferation, and T lymphocyte apoptosis from baseline to after 72 weeks. We also evaluated efficacy at 24- and 48-week intervals to better understand the dynamics of the trial drug’s efficacy. Results: There was a significant increase in CD4+ cell counts in groups treated with the Shenling Guben Granules after 24 weeks, 48 weeks, and 72 weeks of treatment (P<0.05), and the difference in CD4+ cell counts at 24 weeks of treatment was statistically significant (P=0.010). After 48 and 72 weeks of therapy, the CD4+CD38+ cell counts in the Shenling Guben Granules group were significantly higher than in the control group (P<0.05). In the subgroup analysis of CD4+ cell counts ≥200 cells/mm3, the CD4+ cell counts in the treatment group were higher than the control group after treatment for 24, 48, and 72 weeks (P<0.05). Discussion: CD4 cell counts in HIV/AIDS patients with immunological reconstitution insufficiency can be improved to a certain extent using Shenling Guben Granules. The greater the CD4 cell count at the start, the better the therapy response. Furthermore, Shenling Guben Granules have the efficacy and safety to prevent aberrant immunological activation. A large sample size, long-term follow-up, and multiple efficacy indicators were employed to assess the therapy’s safety. Our findings will lead to new therapeutic alternatives for HIV/AIDS patients suffering from immune reconstitution deficiency. Clinical Trial Registry: Name of the registry: Sundy on promote the reconstruction of Inadequate responders in HIV/AIDS patients after combined antiretroviral therapy by Shen Ling Gu Ben Granules;Chictr.org.cn Identifier: ChiCTR1800015290, registered on March 21, 2018( http://www.chictr.org.cn/registry.aspx).

Effects of traditional Chinese medicine combined with HAART therapy on the level of toll like receptors mRNA in AIDS patients with incomplete immune reconstitution

Effects of Immune 2 Granule Combined with HAART Therapy treatment on IL-2 and IL-10 mRNA level of HIV/AIDS with Incomplete Immune Recovery

The Impact of Highly Active Antiretroviral Treatment on the Blood Profiles of Patients with Acquired Immune Deficiency Syndrome

Impact of Highly Active Antiretroviral Treatment on Expression of HIV-1 Coreceptors and Ligand Levels in Peripheral Blood from HIV-1 Infected Patients in China

The effect of different HAART regimens on liver function and HIV load of HIV infected children with HCV co-infection

Study of T Cell Subsets and IL-7 Protein Expression in HIV-1-infected Patients after 7 Years HAART

[Expression of CD38 and HLA-DR on CD8+ T Cells in Pediatric AIDS Patients Receiving Highly Active Antiretroviral Therapy (HAART)].

Immune reconstitution in HIV-1 infected individuals with long-term highly active antiretroviral therapy

Traditional Chinese Medicine Interventions in AIDS Immune Reconstruction under Public Health Supervision

Efficacy of integrated Traditional Chinese Medicine and anti-retroviral therapy on immunological nonresponse in patients with human immunodeficiency virus/acquired immunodeficiency syndrome: a Meta-analysis of randomized controlled trials

Clinical observation of effect of traditional Chinese herbs on CD4 count in 807 people living with HIV/AIDS

[Effects of traditional Chinese medicine on CD4 + T cell counts and HIV viral loads during structured treatment interruption in highly active antiretroviral therapy].

Analysis of CD44 and CD95 Expression on CD4+ T Lymphocyte of HIV-1 Infected Subjects after Effective HAART

Clinical Observations on 100 HIV/AIDS Cases Treated with Chinese Herb Aining Granule Plus HAART

Antiretroviral Therapy Combined with Shenling Guben Granules for the Treatment of HIV Infection with Immune Reconstitution Deficiency: A Randomized, Double-Blind, Placebo-Controlled Study

Molecular mechanism of regulating tat protein expression of pingganjiedu TCM in the treatment of AIDS based on network pharmacology

[Impact of Highly Active Antiretroviral Therapy on Plasma MCP-1 and MSP in AIDS Patients].

Utilization of Traditional Chinese Medicines in the Treatment of 200 People Living with HIV/AIDS

Association of IFNL3/IFNL4 Polymorphisms with Efficacy of Highly Active Antiretroviral Therapy in Patients with HIV-1 Infection

[Analysis on Efficacy Action Points of HIV/AIDS Treatment with Traditional Chinese Medicine and Antiretroviral Drugs].

Effects of the Huoxuepeiyuan Principle on Immunologic Reconstitution of AIDS Patients